ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib.

Monique B Nilsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.